Cochrane Abstracts
Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437923/all/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia.
Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/all/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia. Accessed March 19, 2025.
Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/all/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/all/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia
ID - 437923
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/all/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
